Cellosaurus SpESFX-2 (CVCL_WS51)
| Cell line name | SpESFX-2 |
|---|---|
| Synonyms | SpESF-X2; SpESFX clone 2 |
| Accession | CVCL_WS51 |
| Resource Identification Initiative | To cite this cell line use: SpESFX-2 (RRID:CVCL_WS51) |
| Comments | Group: Hybridoma fusion partner cell line. Group: Patented cell line. Group: Serum/protein free medium cell line. Characteristics: Transfected with a hBCL2-EEE-pZeoSV2+ construct. Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine. Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:990; BCL2 (Note=With p.Thr69Glu, p.Ser70Glu and p.Ser87Glu = BCL2-EEE). Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR). Cell type: Plasma cell; CL=CL_0000786. |
| Disease | Mouse multiple myeloma (NCIt: C125417) |
| Species of origin | Mus musculus (Mouse)
(NCBI Taxonomy: 10090)
Breed/subspecies: BALB/c. |
| Hierarchy | Parent: CVCL_WS49 (SpESFX) |
| Sex of cell | Female |
| Age at sampling | Age unspecified |
| Category | Cancer cell line |
| Publications | Patent=US7608425 |
| Cross-references | |
| Encyclopedic resources | Wikidata; Q98132817 |
| Entry history | |
| Entry creation | 05-Jul-2019 |
| Last entry update | 14-Aug-2025 |
| Version number | 8 |